1881 - 1890 of 6466 Results
Title
Year
- Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease2021OPENTitle: Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 104End Page: 104Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00250-2Best OA location URL: https://www.nature.com/articles/s41531-021-00250-2.pdfCitation Count: 19
-
OPENTitle: The Liquid State of RIM1α and RBP Condensates is Maintained by LipidsJournal Name: ACS NanoPublisher: American Chemical Society (ACS)Vol: 19Issue #: 48Start Page: 40789End Page: 40797Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acsnano.5c07661Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acsnano.5c07661?ref=article_openPDFCitation Count: 1
-
OPENTitle: Local Ionic Conditions Modulate the Aggregation Propensity and Influence the Structural Polymorphism of α-SynucleinJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 147Issue #: 16Start Page: 13131End Page: 13145Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/jacs.4c13473Best OA location URL: https://doi.org/10.1021/jacs.4c13473Citation Count: 16
-
OPENTitle: Deep Learning for Fluorescence Lifetime Predictions Enables High-Throughput In Vivo ImagingJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 147Issue #: 26Start Page: 22609End Page: 22621Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/jacs.5c03749Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/jacs.5c03749?ref=article_openPDFCitation Count: 8
-
OPENTitle: Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertensionJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 330End Page: 330Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-023-44683-0Best OA location URL: https://www.nature.com/articles/s41467-023-44683-0.pdfCitation Count: 21
-
OPENTitle: Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMIJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 102End Page: 102Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00241-3Best OA location URL: https://www.nature.com/articles/s41531-021-00241-3.pdfCitation Count: 55
-
OPENTitle: Structural basis of polyamine transport by human ATP13A2 (PARK9)Journal Name: Molecular CellPublisher: Elsevier BVVol: 81Issue #: 22Start Page: 4635End Page: 4649.e8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molcel.2021.08.017Best OA location URL: https://escholarship.org/content/qt0vq3x5sc/qt0vq3x5sc.pdfCitation Count: 49
-
OPENTitle: The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -IIJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 754016End Page: 754016Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.754016Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.754016/pdfCitation Count: 18
-
OPENTitle: Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page: 729635End Page: 729635Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.729635Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.729635/pdfCitation Count: 22
- Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial2021OPENTitle: Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2408End Page: 2412Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28702Best OA location URL: https://doi.org/10.1002/mds.28702Citation Count: 19